Topical Treatment of Scalp Psoriasis With the Fixed Combination of Calcipotriol and Betamethason (Xamiol® Gel)

• Status: Completed
• Trial end date: 2010-05-01
• Target enrollment: 0
• Participant gender: All

Summary

This non-interventional, prospective, non-controlled study of Xamiol® Gel, a fixed combination of calcipotriol and betamethason dipropionate, shall investigate in daily routine the efficacy, tolerability and changes in quality-of-life parameters in patients with scalp psoriasis

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: LEO Pharma
• Treatments: Calcipotriene

Criteria

Inclusion Criteria:

• Patients with scalp psoriasis if a treatment with Xamiol® gel is planned anyway

Exclusion Criteria:

• Contraindications of Xamiol® Gel listed in the German package insert

• Pretreatment with Xamiol® within the last 4 weeks

• Systemic treatment of psoriasis

• UV light therapy